Medtronic Is Downgraded. Citi Says More challenging to ‘Support the Stock.’

Medtronic

stock was downgraded to Neutral from Get by analysts at Citi, who elevated issue about the company’s potential to deliver steady income expansion.

Medtronic

(ticker: MDT) posted its next-quarter earnings Tuesday. Revenue arrived in at $7.59 billion, while Wall Avenue analysts had predicted $7.7 billion.

Medtronic

stock was downgraded to Neutral from Get by analysts at Citi, who elevated issue about the company’s potential to deliver steady income expansion.

Medtronic

(ticker: MDT) posted its next-quarter earnings Tuesday. Revenue arrived in at $7.59 billion, while Wall Avenue analysts had predicted $7.7 billion.